Table 1 Patient characteristics
From: Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients
Patient characteristics | Â | Colon | Rectum | Overall population |
|---|---|---|---|---|
Total no. of patients | Â | 141 | 64 | 215 |
Median age (years) | Â | 70 +/- 12 | 64 +/- 13 | 68 +/- 13 |
Sex | Â | Â | Â | Â |
| Â | male | 62 (44.0%) | 40 (62.5%) | 107 (49.8%) |
| Â | Female | 79 (56.0%) | 24 (37.5%) | 106 (49.3%) |
Location | Â | Â | Â | Â |
| Â | proximal | Â | Â | 77 (35.8%) |
| Â | distal | Â | Â | 136 (63.3%) |
Grade of differentiation | Â | Â | Â | Â |
| Â | poor | 17 (12.1%) | 2 (3.1%) | 19 (8.8%) |
| Â | moderate | 39 (27.7%) | 19 (29.7%) | 63 (29.3%) |
| Â | well | 83 (58.9%) | 39 (60.9%) | 126 (58.6%) |
Stage | Â | Â | Â | Â |
| Â | I | 15 (10.6%) | 15 (23.4%) | 30 (14.0%) |
| Â | II | 53 (37.6%) | 19 (29.7%) | 74 (34.4%) |
| Â | III | 59 (41.8%) | 18 (28.1%) | 80 (37.2%) |
| Â | IV | 13 (9.2%) | 10 (15.6%) | 26 (12.1%) |
Therapy | Â | Â | Â | Â |
Neo-adjuvant | Yes | 1 (0.7%) | 16 (25.0%) | 19 (8.8%) |
| Â | No | 128 (90.8%) | 44 (68.8%) | 178 (82.8%) |
Adjuvant | Yes | 47(61.0%) | 30 (45.9%) | 81 (37.7%) |
| Â | No | 86 (33.3%) | 29 (45.3%) | 119 (55.3%) |
MSI status | Â | Â | Â | Â |
| Â | MSI | 24 (17.0%) | 2 (3.1%) | 27 (12.6%) |
| Â | MSS | 117 (83.0%) | 62 (96.6%) | 188 (87.4%) |